Evaluation of a Multimodal Integrative Medicine and Naturopathy Program in an Outpatient Setting With Focus on Mind-Body Medicine and Mild Water-filtered Infrared-A Whole-body Hyperthermia for Improvement of Symptoms and Quality of Life in Patients With Post-COVID-19-syndrome - a Prospective Randomised Controlled Study -
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 试验地点
- 2
- 主要终点
- Fatigue - Change from week 0 to week 11
研究概览
简要总结
The study aims to identify whether a multimodal integrative naturopathy outpatient clinical concept can improve the symptoms of patients suffering from post-COVID-Syndrome. Main outcome is fatigue. The outpatient clinical programme consists of 11 weeks wherein patients visit the clinic one day per week. The pillars of classical naturopathy are combined with extended naturopathy and complementary procedures. Previous naturopathical studies on patients with chronic fatigue syndrome could find numerous indications that different types of naturopathy can help patients with fatigue.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 to 75 years of age
- •diagnosed with post covid syndrome
- •fatigue with or without myalgia
- •signed declaration of consent
排除标准
- •contraindications for whole body infrared hyperthermia (severe cardiovascular diseases, tumour diseases, acute infections, pregnant and breastfeeding women)
- •Acute and or feverish microbially infections
- •Pleuritic chest pain
- •Relevant shortness of breath
- •Zn Critical illness or intensive medical care because of COVID 19
- •Patients with severe somatic, cardiovascular pneumological, rheumatic, endocrine or neurological comorbidities. Especially neurological disorders accompanied by cognitive impairment, severe liver or kidney disorders.
- •Patients permanently treated with opioids, cannabis, immunosuppressive agents (e.g. corticoids, immunsuppressives) or alpha/beta-a(nta)gonists
- •Patients with pain as a consequence of a severe psychiatric disease (bipolar disorder, psychosis, personality disorder, severe depression, substance abuse) as well as severe systematic disorders or neurological disorders
- •Participation in other clinical studies
结局指标
主要结局
Fatigue - Change from week 0 to week 11
时间窗: before start of intervention (week 0) and afterwards (week 11)
measured with MFI-20 questionnaire and Chalder fatigue scale MFI-20: 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Reduced Activity. Higher total scores correspond with more acute levels of fatigue. Chalder fatigue scale: a questionnaire to measure the severity of tiredness in fatiguing illnesses. The 11-item chalder fatigue scale is often divided into two components: one that measures physical fatigue (questions 1-7) and one that measures mental fatigue (questions 8-11).
次要结局
- Sleep Quality(before start of intervention (week 0) and afterwards (week 11))
- Hospital Anxiety and Depression(before start of intervention (week 0) and afterwards (week 11))
- Quality of life 2(before start of intervention (week 0) and afterwards (week 11))
- Quality of life 1(before start of intervention (week 0) and afterwards (week 11))
- Perceived Stress(before start of intervention (week 0) and afterwards (week 11))
- perceived Pain(before start of intervention (week 0) and afterwards (week 11))
- Resilience(before start of intervention (week 0) and afterwards (week 11))
研究者
Jost Langhorst
Univ.-Prof. Dr. med. (PhD, MD)
Universität Duisburg-Essen